🏅 FDA Orphan Designation
Gammagard Liquid
immune globulin infusion (human)
Manufacturer: Takeda Pharmaceuticals U.S.A., Inc.
Indicated for:
FDA-Approved Indications (1)
Multifocal motor neuropathyOrphan Designation
Maintenance therapy to improve muscle strength and disability in adult patients with Multifocal Motor Neuropathy (MMN).
Indications & Usage
Maintenance therapy to improve muscle strength and disability in adult patients with Multifocal Motor Neuropathy (MMN).
Medical disclaimer: This information is for educational purposes only. Always consult a qualified healthcare provider before making treatment decisions. Data sourced from FDA and current as of our last update.